THRM vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
THRM presents a contradictory profile: a stable balance sheet paired with deteriorating earnings performance. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $29.58 trades at a significant premium to both the Graham Number ($17.7) and the growth-based Intrinsic Value ($4.13). While the Forward P/E of 9.58 suggests a massive expected earnings recovery, the current YoY earnings crash of -81.20% and a bearish technical trend create significant near-term risk. The investment thesis relies entirely on a turnaround in profitability that has not yet materialized in the data.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
THRM vs TSLA: Head-to-Head Comparison
This page compares Gentherm Incorporated (THRM) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.